Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sigrist, 2007, Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease, Clin J Am Soc Nephrol., 2, 1241, 10.2215/CJN.02190507
Kalantar-Zadeh, 2010, Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals, Kidney Int., 117, S10, 10.1038/ki.2010.189
London, 2003, Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrol Dial Transplant., 18, 1731, 10.1093/ndt/gfg414
Persy, 2009, Vascular calcification and bone disease: the calcification paradox, Trends Mol Med., 15, 405, 10.1016/j.molmed.2009.07.001
Towler, 2015, Arteriosclerosis, bone biology, and calciotropic hormone signaling: learning the ABCs of disease in the bone-vascular axis, J Am Soc Nephrol., 26, 243, 10.1681/ASN.2014080824
Neven, 2009, Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats, Nephrol Dial Transplant., 24, 1790, 10.1093/ndt/gfn737
De Schutter, 2013, Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia, Kidney Int., 83, 1109, 10.1038/ki.2013.34
Block, 2005, Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis, Kidney Int., 68, 1815, 10.1111/j.1523-1755.2005.00600.x
Neven, 2010, Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats, Arterioscler Thromb Vasc Biol., 30, 1741, 10.1161/ATVBAHA.110.204834
Price, 2006, Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate, Kidney Int., 70, 1577, 10.1038/sj.ki.5001841
Dempster, 2013, Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee, J Bone Miner Res., 28, 2, 10.1002/jbmr.1805
Neven, 2011, Cell biological and physicochemical aspects of arterial calcification, Kidney Int., 79, 1166, 10.1038/ki.2011.59
Massy, 2005, Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice, J Am Soc Nephrol., 16, 109, 10.1681/ASN.2004060495
Nikolov, 2010, Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure, Bone., 47, 156, 10.1016/j.bone.2010.04.600
Moe, 2009, A rat model of chronic kidney disease-mineral bone disorder, Kidney Int., 75, 176, 10.1038/ki.2008.456
Shobeiri, 2013, Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences, J Hypertens., 31, 160, 10.1097/HJH.0b013e32835b15bb
Isakova, 2011, Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease, Kidney Int., 79, 1370, 10.1038/ki.2011.47
Giachelli, 2003, Vascular calcification: in vitro evidence for the role of inorganic phosphate, J Am Soc Nephrol., 14, S300, 10.1097/01.ASN.0000081663.52165.66
Yang, 2004, Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro, Kidney Int., 66, 2293, 10.1111/j.1523-1755.2004.66015.x
De Schutter, 2011, Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox, Am J Nephrol., 34, 356, 10.1159/000331056
Kiel, 2001, Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study, Calcif Tissue Int., 68, 271, 10.1007/BF02390833
Naves, 2008, Progression of vascular calcifications is associated with greater bone loss and increased bone fractures, Osteoporos Int., 19, 1161, 10.1007/s00198-007-0539-1
Ragnauth, 2010, Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging, Circulation., 121, 2200, 10.1161/CIRCULATIONAHA.109.902056
Liu, 2013, Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells, Circ Res., 112, e99, 10.1161/CIRCRESAHA.111.300543
Nguyen-Khoa, 2001, Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment, Nephrol Dial Transplant., 16, 335, 10.1093/ndt/16.2.335
Brandenburg, 2013, Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study, BMC Nephrol., 14, 219, 10.1186/1471-2369-14-219
Claes, 2013, Sclerostin: another vascular calcification inhibitor?, J Clin Endocrinol Metab., 98, 3221, 10.1210/jc.2013-1521
Hampson, 2013, The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women, Bone., 56, 42, 10.1016/j.bone.2013.05.010
Koos, 2013, Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study, J Heart Valve Dis., 22, 317
Zhu, 2011, The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells, PLoS One., 6, e19595, 10.1371/journal.pone.0019595
Lim, 2012, Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23, Circulation., 125, 2243, 10.1161/CIRCULATIONAHA.111.053405
Fang, 2014, Early chronic kidney disease-mineral bone disorder stimulates vascular calcification, Kidney Int., 85, 142, 10.1038/ki.2013.271
Jimbo, 2014, Cardiovascular risk factors and chronic kidney disease-FGF23: a key molecule in the cardiovascular disease, Int J Hypertens., 2014, 381082, 10.1155/2014/381082
van Venrooij, 2014, FGF23 protein expression in coronary arteries is associated with impaired kidney function, Nephrol Dial Transplant., 29, 1525, 10.1093/ndt/gft523
Donate-Correa, 2013, Expression of FGF23/KLOTHO system in human vascular tissue, Int J Cardiol., 165, 179, 10.1016/j.ijcard.2011.08.850
Zhu, 2013, A protective role for FGF-23 in local defence against disrupted arterial wall integrity?, Mol Cell Endocrinol., 372, 1, 10.1016/j.mce.2013.03.008
Jimbo, 2014, Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency, Kidney Int., 85, 1103, 10.1038/ki.2013.332
Moreno, 2011, The inflammatory cytokines TWEAK and TNFalpha reduce renal klotho expression through NFkappaB, J Am Soc Nephrol., 22, 1315, 10.1681/ASN.2010101073
Antoine, 2006, Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation, Biochem Biophys Res Commun., 346, 224, 10.1016/j.bbrc.2006.05.105